Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
New Delhi, Feb 1 (PTI) The budget allocation for the Ministry of Ayush has been increased to Rs 3,992.90 crore for 2025-26 from Rs 3,497.64 crore (revised estimates) in 2024-25, a 14.15 per cent hike.
The National Medicinal Plants Board has been allocated Rs 18.59 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) has been allocated Rs 21.96 crore.
The National Medicinal Plants Board undertakes promotional and contractual farming schemes to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H (Ayurveda, Siddha, Unani and Homeopathy) medicines.
The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for testing of all Ayush drugs in India. It also sets the standards for all Ayush drugs that are published in the form of pharmacopoeias.
The autonomous bodies have been allocated Rs 1,965.80 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 457.20 crore, Central Council for Research in Homeopathy has been given Rs 165 crore, Central Council for Research in Unani Medicine has been given Rs 214.50 crore and All India Institute of Ayurveda has been given Rs 251.20 crore. PTI PLB DIV DIV
Budget allocation increase for traditional medical systems boosts funding for medicinal plants conservation and pharmacopoeial standards. Increased budgetary appropriations for the traditional medicine sector channel additional funding to entities tasked with conserving and cultivating medicinal plants through promotional and contractual farming schemes to ensure quality raw materials, and to the pharmacopoeial authority responsible for testing oversight and for setting published standards for Ayush drugs. A significant share of the increase is allocated to autonomous research bodies and an institute to support research, standards implementation, and institutional capacity in traditional medicine.Press 'Enter' after typing page number.